Salvati F,Teodori L,Trinca ML,et al. The relevance of flow-cytom etric DNA content in the evaluation of lung cancer[J]. Cancer Res Clin Oncol,1994 ,120(4):233-239.
[2]
Liewald F,Sunder-Plassmann L,Dienemann H,et al. Prognostic value of f low cytometrically determined DNA-ploidy,intracellular pH and esterase activity of non-small cell lung carcinomas[J]. Anal Cell Pathol,1992,4(2):103-114 .
[3]
Carey FA,Prasad US,Walker WS,et al. Prognostic significance of tumor deoxyribonucleic acid content in surgically resected small-cell carcinoma of lun g[J]. J Thorac Cardiovasc Surg,1992,103(6):1214-1217.
[4]
Pence JC,Kerns BJ,Dodge RK,et al. Prognostic significance of the prol iferation index in surgically resected non-small-cell lung cancer[J]. Arch Su rg,1993,128(12):1382-1390.
[5]
Ranaldi R,Santinelli A,Fabris G,et al. A flow cytometric study of ea rly gastric cancer. The detection of high proliferative activity adds important information to the prognosis[J].Pathol Res Pract,1996,192(12):1202-1205.
[6]
Wu Yun fei,Xu Hui mian,Chen Jun qing. Relations of proliferati ve act ivities of gastric carcinoma cells to lymphatic involvement,venous invasion and prognosis[J].Chin Med J,2004,117(10):1530-1535.
[7]
Antonio Russo,Viviana Bazan,Manuela Migliavacca,et al. Prognostic Sign ificance of DNA Ploidy,S-Phase Fraction,and Tissue Levels of Aspartic,Cystein e,and Serine Proteases in Operable Gastric Carcinoma[J].Clinical Cancer Res earch,2000,(6):178-184.
[8]
Kumar D,Kumar S,Lyon D. Comparison of flow cytometric DNA c ontent anal ysis of fresh and formalin-fixed paraffin-embedded solid neoplasms[J]. Mod Pa thol,1994,7(3):354-360.
Isobe H,Miyamoto H,Shimizu T,et al. Prognostic and therapeutic signif icance of the flow cytometric nuclear DNA content in non-small cell lung cancer [J]. Cancer,1990,65(6):1391-1395.
[11]
Merkel DE,McGuire WL. Ploidy,proliferative activity and prognosis DNA flow cytometry of solid tumors[J].Cancer,1990,65(5):1194-1205.
[12]
O Stal,M Dufmats,T Hatschek,et al. S-phase fraction is a prognostic f actor in stage I breast carcinoma[J].Journal of Clinical Oncology,1993,11:1 717-1722.
[13]
Kute TE,Quadri Y,Muss H,et al. Flow cytometry in node-positive breas t cancer: cancer and leukemia group B protocol 8869[J]. Cytometry,1995,22(4): 297-306.
[14]
Agnès Chassevent,Marie-Lise Jourdan,Sylvie Romain,et al. S-Phase Fra ction and DNA Ploidy in 633 T1T2 Breast Cancers[J].Clinical Cancer Research ,2001,7: 909-917.
[15]
GM Clark,LG Dressler,MA Owens,et al. Prediction of relapse or survi val in patients with node-negative breast cancer by DNA flow cytometry[J]. T he New England Journal of Medicine,1989,320:627-633.
[16]
Carey FA,Lamb D,Bird CC. Intratumoral heterogeneity of DNA content in lung cancer[J]. Cancer,1990,65(10):2266-2269.
[17]
Beerman H,Smit VT,Kluin PM,et al. Flow cytometric analysis of DNA st emline heterogeneity in primary and metastatic breast cancer[J].Cytometry, 1991,12(2):147-154.
[18]
Toshio Imada,Yuji Yamamoto,Kuniyasu Fukuzawa,et al. Flow Cytometric Analysis of Nuclear DNA Heterogeneity in Gastric Cancer[J]. Japanese Journal of Clinical Oncology,1998,(3):221-226.
[19]
Kim JY,Cho Hj. DNA ploidy patterns in gastric adenocarcinoma[J]. Ko rean Med Sci,2000,15(2):159-166.
